Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Scleroderma
(1993): Choy E+, Br J Rheumatol 32, 160
Squamous cell carcinoma
(2003): Li AC+, Eur J Gastroenterol Hepatol 15(2), 185
(2001): Otley CC+, Arch Dermatol 137, 459
(2001): Werth V, Dermatology Times 15
(1995): Bottomley WW+, Br J Dermatol 133, 460
(1993): Nachbar F+, Acta Derm Venereol 73, 217
(1992): McCain J, Nurs Pract 17, 13
(1988): Krickeberg H, ZHautkr(German) 63, 773
Stevens–Johnson syndrome
(2004): Mori H+, JDermatol31(9), 731
Tinea
(1981): Burkhart CG+, Cutis 27(1), 56
(1980): L’Eplattenier JL+, Schweiz Med Wochenschr (German)
110, 1307 (3%)
Toxic epidermal necrolysis
(1990): Black AK+, Br J Dermatol 123, 277
Urticaria
(1995): Knowles SR+, Clin Exp Dermatol 20, 353 (passim)
(1990): Wijnands MJ+, Scand J Rheumatol 19, 167
(1988): Saway PA+, Am J Med 84, 960 (passim)
Vasculitis
(2005): Appelman M+, Dermatology 210(4), 366
(2003): Sinico RA+, JNephrol16(2), 272
(1995): Blanco R+, Arthritis Rheum 39, 1016
(1995): Knowles SR+, Clin Exp Dermatol 20, 353 (passim)
(1988): Bergman SM+, AnnInternMed109, 83
Verrucae
(2006): Patel AA+, JAmAcadDermatol55(3), 369
(1991): Callen JP+, Arch Dermatol 127, 515
(1980): L’Eplattenier JL+, Schweiz Med Wochenschr (German)
110, 1307 (21%)
Mucosal
Aphthous stomatitis (